Leyden Labs Raises Funding for Respiratory Virus Nasal Spray Programs
Amsterdam biotechnology company Leyden Labs has secured new financing to advance clinical development of nasal sprays designed to provide protection against families of respiratory viruses, supporting research within the Netherlands' life sciences sector.